Synjardy

Active Ingredient(s): Empagliflozin + Metformin Hydrochloride
FDA Approved: * August 26, 2015
Pharm Company: * BOEHRINGER INGELHEIM
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Synjardy Overview

Empagliflozin (trade name Jardiance) is a drug of the gliflozin class, approved for the treatment of type 2 diabetes in adults in 2014. It was developed by Boehringer Ingelheim and Eli Lilly and Company.[1] Empagliflozin is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), and causes sugar in the blood to be excreted by the kidneys and eliminated in urine. Contents 1 Medical use 2 Side effects 3 Mode of action 4 Regulatory status 5 See also 6 References Me...

Read more Synjardy Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Empagliflozin

Recent Synjardy Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Empagliflozin + Metformin Hydrochloride
  • Tablet: 12.5mg + 1gm, 12.5mg + 500mg, 12.5mg/1000mg, 12.5mg/500mg, 5mg + 1gm, 5mg + 500mg, 5mg/1000mg, 5mg/500mg
  • Tablet, Extended Release: 10mg + 1gm, 12.5mg + 1gm, 25mg + 1gm, 25mg + 2000mg, 5mg + 1gm
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Synjardy: (4 results)

Sorted by National Drug Code
  • 0597-0159 Synjardy Oral Tablet by Boehringer Ingelheim Pharmaceuticals, Inc.
  • 0597-0168 Synjardy Oral Tablet by Boehringer Ingelheim Pharmaceuticals, Inc.
  • 0597-0175 Synjardy Oral Tablet by Boehringer Ingelheim Pharmaceuticals, Inc.
  • 0597-0180 Synjardy Oral Tablet by Boehringer Ingelheim Pharmaceuticals, Inc.

Drugs with one or more similar ingredients: (27 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA